Company profile
Cytospire Therapeutics
Cytospire Therapeutics is bringing forward a portfolio of next generation immune cell engagers.
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
RESOLUTIONS | Transaction WUYxVVZBU0lhZGlxemtjeA | Paper/PDF filed
Published 29 May 2026 01:47
MA | Transaction MzUyMDY2MTY5M2FkaXF6a2N4 | Paper/PDF filed
Published 29 May 2026 01:11
AP01 | Transaction MzUxNDExNzIyMmFkaXF6a2N4
Published 02 Apr 2026 13:37
SH01 | Transaction MzUxNDExNzIyNWFkaXF6a2N4
Published 02 Apr 2026 13:37
MA | Transaction MzUxMTY5ODgwMmFkaXF6a2N4 | Paper/PDF filed
Published 28 Mar 2026 14:23
RESOLUTIONS | Transaction WUVZOVpDTUphZGlxemtjeA | Paper/PDF filed
Published 28 Mar 2026 14:22
Last confirmation statement made up date
Last accounts made up date
PSC07 | Transaction MzQ0MDA4ODM0NWFkaXF6a2N4
Published 21 Oct 2024 02:14
SH01 | Transaction MzQzOTE1MzM0M2FkaXF6a2N4
Published 11 Oct 2024 09:48
Company registered at Companies House
